Grand challenge for ion channels: An underexploited resource for therapeutics

Frontiers in Pharmacology

Volumn AUG, Issue , 2010, Pages

  Camerino, Diana Conte ^a   Desaphy, Jean François ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856233436     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2010.00113     Document Type: Article

References (14)

1. Amaral, M. D. (2006). Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease. J. Inherit. Metab. Dis. 29, 477-487.
2. Castle, N., Printzenhoff, D., Zellmer, S., Antonio, B., Wickenden, A., and Silvia, C. (2009). Sodium channel inhibitor drug discovery using automated high throughput electrophysiology platforms. Comb. Chem. High Throughput Screen. 12, 107-122.
3. Chaitman, B. R. (2006). Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113, 2462-2472.
4. Conte Camerino, D., Desaphy, J.-F., Tricarico, D., Pierno, S., and Liantonio, A. (2008). Therapeutic approaches to ion channel diseases. Adv. Genet. 64, 81-145.
5. Conte Camerino, D., Tricarico, D., and Desaphy, J.-F. (2007). Ion channel pharmacology. Neurother. 4, 184-198.
6. Dworkin, R. H., O'Connor, A. B, Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, J. T. J., Portenoy, R. K., Rice, A. S. C., Stacey, B. R., Treede, R.-D., Turk, D. C., and Wallace, M. S. (2007). Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132, 237-251.
7. Godfraind, T. (2005). Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. Phil. Trans. R. Soc. B 360, 2259-2272.
8. Godfraind, T. (2006). Calcium-channel modulators for cardiovascular disease. Expert Opin. Emerg. Drugs 11, 49-73.
9. Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membranes patches. Pflugers Arch. 391, 85-100.
10. Hodgkin, A. L., and Huxley, A. F. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117, 500-544.
11. Jarvis, M. F., Honore, P., Shieh, C. C., Chapman, M., Joshi, S., Zhang, X. F., Kort, M., Carroll, W., Marron, B., Atkinson, R., Thomas, J., Liu, D., Krambis, M., Liu, Y., McGaraughty, S., Chu, K., Roeloffs, R., Zhong, C., Mikusa, J. P., Hernandez, G., Gauvin, D., Wade, C., Zhu, C., Pai, M., Scanio, M., Shi, L., Drizin, I., Gregg, R., Matulenko, M., Hakeen, A., Gross, M., Johnson, M., Marsh, K., Wagoner, K., Sullivan, J. P., Faltynek, C. R., and Krafte, D. (2007). A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc. Natl. Acad. Sci. U.S.A. 104, 8520-8525.
12. MacKinnon, R. (2004). Nobel lecture. Potassium channels and the atomic basis of selective ion conduction. Biosci. Rep. 24, 75-100.
13. Sokolov, S., Scheuer, T., and Catteral, W. A. (2010). Ion permeation and block of the gating pore in the voltage sensor of Nav1.4 channels with hypokalemic periodic paralysis mutation. J. Gen. Physiol. 136, 225-236.
14. Williams, B. S., Felix, J. P., Priest, B. T., Brochu, R. U., Dai, K., Hoyt, S. B., London, C., Tang, Y. S., Duffy, J. L., Parsons, W. H., Kaczorowski, G. J., and Garcia, M. (2007). Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7. Biochemistry 46, 14693-14703.